uniQure NV News - QURE

Company Name	Stock Ticker Symbol	Market	Type
uniQure NV	QURE	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.03	0.66%	4.57	17:52:38

Open Price	Low Price	High Price	Close Price	Prev Close
4.55	4.45	4.625	4.53	4.54

more quote information »

Recent News

Date	Time	Source	Heading
3/05/2024	17:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/05/2024	17:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/05/2024	16:58	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/05/2024	16:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/28/2024	16:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/28/2024	08:29	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2/28/2024	08:00	EDGAR2	Form 8-K - Current report
2/28/2024	07:05	GLOBE	uniQure Announces 2023 Financial Results and Highlights..
2/26/2024	16:46	EDGAR2	Form 144 - Report of proposed sale of securities
2/26/2024	16:25	EDGAR2	Form 144 - Report of proposed sale of securities
2/13/2024	16:33	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
12/19/2023	07:12	EDGAR2	Form 8-K - Current report
12/19/2023	07:05	GLOBE	uniQure Announces Update on Phase I/II Clinical Trials of..
12/11/2023	19:30	PRNUS	CSL Behring's HEMGENIX® (etranacogene dezaparvovec-drlb)..
12/08/2023	07:05	GLOBE	uniQure Announces Inducement Grants Under Nasdaq Listing..
11/29/2023	07:05	GLOBE	uniQure Announces FDA Clearance of Investigational New Drug..
11/17/2023	06:00	EDGAR2	Form 8-K - Current report
11/07/2023	07:52	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/2023	07:31	EDGAR2	Form 8-K - Current report
11/07/2023	07:05	GLOBE	uniQure Announces Third Quarter 2023 Financial Results and..
10/27/2023	10:00	PRNUS	CSL and uniQure Win 2023 Prix Galien USA Award
10/26/2023	14:38	PRNCA	Santé Canada autorise HEMGENIX® de CSL (étranacogène..
10/26/2023	14:14	PRNCA	Health Canada Authorizes CSL's HEMGENIX® (etranacogene..
10/24/2023	07:05	GLOBE	uniQure Announces Major Presence at the European Society of..
10/06/2023	06:33	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
10/06/2023	06:32	EDGAR2	Form DEF 14A - Other definitive proxy statements
10/05/2023	16:32	EDGAR2	Form 8-K - Current report
10/05/2023	07:05	GLOBE	uniQure Announces Strategic Reorganization to Reduce..
10/02/2023	21:50	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
10/02/2023	07:05	GLOBE	uniQure Announces Inducement Grants Under Nasdaq Listing..
9/20/2023	16:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/05/2023	13:59	DJN	Re/Max, UniQure and Trinseo Fall to 52-Week Lows on Exit..
9/05/2023	07:05	GLOBE	uniQure Announces FDA Clearance of Investigational New Drug..
9/01/2023	18:51	PRNUS	Blackstone and Airbnb Set to Join S&P 500; Others to Join..
8/01/2023	16:30	EDGAR2	Form 8-K - Current report
8/01/2023	07:37	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/01/2023	07:05	GLOBE	uniQure Announces Second Quarter 2023 Financial Results and..
7/12/2023	16:49	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/10/2023	10:58	EDGAR2	Form 144 - Report of proposed sale of securities
6/26/2023	07:11	GLOBE	uniQure Announces Leadership Addition to Support Advancement..
6/21/2023	07:05	GLOBE	uniQure Announces Update on U.S. Phase I/II Clinical Trial..
6/20/2023	07:05	GLOBE	uniQure announces achievement of $100 million..
6/20/2023	07:00	PRNUS	CSL Behring Announces the First Patient Has Received..
6/16/2023	07:05	GLOBE	uniQure Announces Inducement Grants Under Nasdaq Listing..
5/15/2023	07:05	GLOBE	uniQure Announces Sale of Royalty Interest in HEMGENIX® for..
5/09/2023	07:05	GLOBE	uniQure Announces First Quarter 2023 Financial Results and..
5/02/2023	16:40	GLOBE	uniQure Announces Major Presence at Upcoming American..
5/02/2023	07:05	GLOBE	uniQure Announces Inducement Grants Under Nasdaq Listing..